Is it cheap or expensive right now?

Latest price vs our fair value. A comparison, not a recommendation.

In plain terms: Burjeel trades at AED 1.11 — just below our weighted bear case of 1.14, and far under the weighted central fair value of 1.85. That geometry is the whole story: the market is pricing a scenario where the margin never leaves the high-teens, a full 15% minimum tax applies with no substance relief, receivables stay stuck at 135 days, Saudi stays a rounding error, and a management team that guided a 23.5% margin and delivered 18.1% is extended no credit — and then discounts a little further. Two things push the other way. First, the tax: the UAE’s 15% top-up applies only to income above a substance-based carve-out (payroll + tangible assets), and Burjeel’s own FY2025 filing shows a 7.0% effective rate — a mechanics-driven path toward 10–13%, not the flat 15% the market seems to assume. Second, the cash: FY2025 absorbed AED 649mn of operating surplus into working capital before it ever reached the cash-flow statement, which is why the 7.00% five-year sukuk priced where it did and why the dividend was cut. Both are real risks, not sourcing errors — the receivables clock has to turn for the DCF case to matter at all. What moves the price near-term is the FY2025 DMTT return (filed 2026–27, the single document that reweights every lens at once) and the H1-2026 results, due mid-August, the first full read on whether the margin recovery and the receivables cycle are turning.

Key levels

The 5th–95th and 25th–75th percentile bands from the 50,000-path simulation. Static and pre-computed — independent of the fundamental value.

What drives the odds

50,000 paths, carry-anchored to the UAE production panel: the Pillar-Two tax path (10→13% mechanics vs a flat-15% assessment), the pace at which DSO normalizes off 135 days, the margin mix between fast-growing oncology and the group’s surgical base, the 7.00% sukuk’s funding-cost read-through, and the FY2025 DMTT return itself (filed 2026–27) which can reweight every lens at once. Genuinely thin float (~11%, some undisclosed buyback execution) keeps idiosyncratic volatility high relative to the panel. Details in the methodology.